Dow Up 0.00% Nasdaq Up 0.09%

NovaBay Pharmaceuticals, Inc. (NBY)

-NYSE MKT
0.71 Down 0.01(0.85%) Nov 28, 1:00PM EST
Prev Close:0.72
Open:0.70
Bid:0.49 x 100
Ask:1.00 x 100
1y Target Est:1.45
Beta:0.37
Next Earnings Date:N/A
Day's Range:0.70 - 0.72
52wk Range:0.69 - 1.48
Volume:35,011
Avg Vol (3m):172,126
Market Cap:36.65M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBY

Comparison

Symbol% ChgMkt Cap
NBYDown 0.85%36.65M
ABTUp 0.59%67.02B
PFEUp 0.16%196.27B
SNNDown 2.94%15.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):34.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.30
Quarterly EPS Est (Dec-14) :-0.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing product candidates for the therapeutic needs of anti-infective market. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback